Legal status · Australia
Is KN069 legal in Australia?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. KN069 is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
KN069 in Australia at a glance
| Classification | Investigational, not registered |
|---|---|
| TGA approval status | Not approved by TGA; investigational |
| Human studies cited | 2 of 2 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the KN069 profile, checked against Therapeutic Goods Administration (TGA) listings at the reviewed date.
What this means
- 01
KN069 is being studied in registered clinical trials but has not received TGA marketing approval in Australia.
- 02
Lawful human access is limited to trial participation or a formal early-access scheme where one exists; there is no pharmacy product to prescribe.
- 03
Vials sold online "for research use only" are not trial material, and that label does not make human use lawful.
What KN069 is
Mechanistically the opposite of tirzepatide in one molecule, and it also produced weight loss. Its half-life is 37 to 46 days, among the longest of any agent on this site.
Tirzepatide activates the GIP receptor. This drug blocks it, while activating GLP-1 in the same molecule.
Mechanism: A single molecule combining GLP-1 receptor agonism with GIP receptor antagonism. The GLP-1 half reduces food intake and improves glycaemic control conventionally.
Regulatory history: Investigational. Phase 1 only. Not approved anywhere.
How TGA treats this kind of product
Registers or lists therapeutic goods on the ARTG and schedules substances in the Poisons Standard. Many peptides are Schedule 4 (prescription only), so possession without a prescription and personal importation are restricted even when no product is registered.
The classification above is the The Longevity Archive reading of Therapeutic Goods Administration listings for KN069 at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
KN069 in other countries
Frequently asked questions
Is KN069 legal in Australia?
No. KN069 is not approved for any medical use in Australia; its classification is "Investigational, not registered". Lawful access is limited to registered clinical trials. "Research use only" labeling on vials sold online does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Can I buy KN069 in Australia?
No approved product exists to buy. In Australia KN069 is classified as "Investigational, not registered", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is KN069 TGA approved?
No. In Australia KN069 is classified as "Investigational, not registered", which is not a TGA marketing approval. For comparison, the US FDA status is: Investigational. Phase 1 only. Not approved anywhere.. On the evidence, 2 human studies are cited on its profile.
Related compounds in Australia
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for KN069 live on its compound profile.
KN069 profileThis page is general information about the regulatory status of KN069 in Australia, current as of Sep 2026. It is not legal advice, and classifications change; check Therapeutic Goods Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.